Literature DB >> 12435868

A case of autoimmune pancreatitis responding to steroid therapy. Evidence of histologic recovery.

Takeshi Saito1, Shigeki Tanaka, Hitoshi Yoshida, Tsunao Imamura, Junichi Ukegawa, Tetsuya Seki, Akitoshi Ikegami, Fuyuhiko Yamamura, Tetsuya Mikami, Yuji Aoyagi, Junichi Niikawa, Keiji Mitamura.   

Abstract

We report a case of autoimmune pancreatitis without obvious evidence of autoimmunological participation, which responded well to steroid treatment and provided histologic and radiographic evidence for this improvement. A 68-year-old woman presented abdominal fullness, diffuse pancreatic swelling on abdominal computed tomography and ultrasonography, and diffuse narrowing of the main pancreatic duct on endoscopic retrograde pancreatography. Transgastric aspiration needle biopsy of the body of the pancreas performed under endoscopic ultrasonography showed severe atrophy of acinar cells, infiltration of T lymphocytes. She was diagnosed as having autoimmune pancreatitis without obvious evidence of autoimmunological participation. Administration of 30 mg/day of predonisolone was started. Computed tomography showed marked improvement of the diffuse swelling of the pancreas, and endoscopic retrograde pancreatograpy showed amelioration of the narrowing of the main pancreatic duct after the start of treatment. Pancreatic tissue obtained by needle biopsy after the start of treatment with predonisolone revealed marked histologic improvement, including amelioration of the fibrosis, and infiltration of inflammatory lymphocytes, and a substantial increase in the number of pancreatic acinar cells. The present report is the first to demonstrate histologic recovery of autoimmune pancreatitis after steroid therapy. Copyright 2002 S. Karger AG, Basel and IAP

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435868     DOI: 10.1159/000066092

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  14 in total

Review 1.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 2.  Histopathology of autoimmune pancreatitis: recognized features and unsolved issues.

Authors:  Mari Mino-Kenudson; Gregory Y Lauwers
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

3.  Autoimmune sclerosing pancreatitis: the surgeon's perspective.

Authors:  Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

Review 4.  [Autoimmune pancreatitis--a surgical disease?].

Authors:  J Kleeff; T Welsch; I Esposito; M Löhr; R Singer; M W Büchler; H Friess
Journal:  Chirurg       Date:  2006-02       Impact factor: 0.955

Review 5.  Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions.

Authors:  Günter Klöppel; Sönke Detlefsen; Suresh T Chari; Daniel S Longnecker; Giuseppe Zamboni
Journal:  J Gastroenterol       Date:  2010-06-12       Impact factor: 7.527

6.  Autoimmune pancreatitis: functional and morphological recovery after steroid therapy.

Authors:  László Czakó; Eva Hegyközi; Attila Pálinkás; János Lonovics
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 7.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 8.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 9.  IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.

Authors:  Sönke Detlefsen; Günter Klöppel
Journal:  Virchows Arch       Date:  2017-12-01       Impact factor: 4.064

Review 10.  Autoimmune pancreatitis: histo- and immunopathological features.

Authors:  Günter Klöppel; Bence Sipos; Giuseppe Zamboni; Motohiro Kojima; Toshio Morohoshi
Journal:  J Gastroenterol       Date:  2007-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.